iZafe Group Past Earnings Performance

Past criteria checks 0/6

iZafe Group's earnings have been declining at an average annual rate of -10.1%, while the Healthcare Services industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 46.3% per year.

Key information

-10.1%

Earnings growth rate

31.5%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate-46.3%
Return on equity-204.6%
Net Margin-508.7%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How iZafe Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:M02 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246-32160
30 Jun 245-32150
31 Mar 245-33150
31 Dec 232-32140
30 Sep 231-20150
30 Jun 231-21160
31 Mar 231-22160
31 Dec 221-24190
30 Sep 221-31250
30 Jun 221-31250
31 Mar 221-34270
31 Dec 210-36270
30 Sep 211-32240
30 Jun 211-19260
31 Mar 215-16270
31 Dec 209-13290
30 Sep 2013-11310
30 Jun 2016-22310
31 Mar 2015-23180
31 Dec 1914-23310
30 Sep 1915-18250
30 Jun 1914-16220
31 Mar 1911-14100
31 Dec 188-1170
30 Sep 183-1140
30 Jun 181-1020
31 Mar 181-710
31 Dec 171-410
30 Sep 170-210
30 Jun 170-200
31 Mar 170-600
31 Dec 160-600
30 Sep 160-700
30 Jun 160-700
31 Mar 160-300
31 Dec 150-310
30 Sep 150-320
30 Jun 150-310
31 Mar 150-310
31 Dec 140-310
30 Sep 140-700
30 Jun 140-710
31 Mar 140-400

Quality Earnings: M02 is currently unprofitable.

Growing Profit Margin: M02 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: M02 is unprofitable, and losses have increased over the past 5 years at a rate of 10.1% per year.

Accelerating Growth: Unable to compare M02's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: M02 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).


Return on Equity

High ROE: M02 has a negative Return on Equity (-204.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 05:20
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

iZafe Group AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jesper Birch-JensenABG Sundal Collier Sponsored